Obituary
2002
Obituary for Tom Connors
Editorial
Author Information
Author(s): John Double
Conclusion
Tom Connors made significant contributions to cancer research and drug development, particularly in the evaluation of cisplatin and the development of carboplatin.
Supporting Evidence
- Tom Connors was involved in cancer research for over 40 years.
- He was a leading authority in the development of new anti-cancer drugs.
- Connors was the first to evaluate the antitumor potential of cisplatin.
Takeaway
Tom Connors was a key figure in cancer research who helped create important cancer drugs and taught many people in the field.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website